Table 3.

Factors associated with telomere length (T/S ratio) by cocaine use status, robust regression analyses^*

Characteristic	Univariate model Regression coefficient (95%CI) p-value	Initial multivariate model Regression coefficient (95%CI) p-value	Final multivariate model Regression coefficient (95%CI) p-value
Never cocaine use (N=22)
Daily alcohol use	−0.0510(−0.4024, 0.0305) 0.77	−0.0548(−0.4210, 0.3114) 0.77
Low 2013 risk	0.0223(−0.2287, 0.2734) 0.86	0.0586(−0.2111, 0.3283) 0.67
NNRTI use	0.1759(−0.1020, 0.4538) 0.21	0.1983(−0.1029, 0.4995) 0.20
Chronic cocaine use (N=125)
Daily alcohol use	−0.1118(−0.1801,−0.0435) 0.001	−0.1174(−0.1819,−0.0529) 0.0004	−0.1174(−0.1819,−0.0529) 0.0004
Low 2013 risk	0.0884( 0.0187, 0.1581) 0.01	0.0917(0.0270, 0.1563) 0.005	0.0917(0.0270, 0.1563) 0.005
NNRTI use	0.1007( 0.0103, 0.1910) 0.029	0.0865(0.0032,0.1699) 0.04	0.0865(0.0032,0.1699) 0.04

^*low 2013 risk, cardiovascular risk defined by the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk≤7.5% (Goff et al., 2014),

NNRTI, non-nucleoside reverse transcriptase inhibitor.